V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003431 | 310001439 | 1.61 | 91 | Palliative (P) | 2015-01-02 | 2015-01-14 | Carboplatin + Etoposide IV 3 day | N | N | 310017922 | CARBOPLATIN + ETOPOSIDE |
| 310003432 | 310006611 | 1.87 | 70.4 | Curative (C) | 2017-04-21 | 2017-04-23 | CHOP R - 21 days | N | N | 310017924 | CHOP R |
| 310003433 | 310006611 | 1.8 | 69 | Curative (C) | 2013-09-15 | 2013-09-17 | CHEMO-T TRIAL | 1 | N | 310017924 | TRIAL |
| 310003434 | 310006611 | 1.67 | 50.5 | Disease modification (D) | 2017-11-17 | 2017-12-01 | Trial Unspecified | 1 | N | 310017924 | TRIAL |
| 310003435 | 310006611 | 1.57 | 56 | Not known (9) | 2016-08-09 | 2016-08-09 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310017924 | CISPLATIN + GEMCITABINE |
| 310003436 | 310006611 | 1.72 | 73.9 | Palliative (P) | 2017-12-15 | 2017-12-16 | Ipilimumab | N | N | 310017924 | IPILIMUMAB |
| 310003437 | 310011662 | 1.6 | 81.5 | Neo-adjuvant (N) | 2017-12-03 | 2018-01-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017932 | CISPLATIN + GEMCITABINE |
| 310003439 | 310001441 | null | null | Curative (C) | 2015-06-01 | 2015-06-15 | CHOP R - 21 days | N | N | 310017935 | CHOP R |
| 310003440 | 310006612 | 1.88 | 72 | Curative (C) | 2013-08-06 | 2013-08-07 | CHOP R - 21 days | 2 | N | 310017938 | CHOP R |
| 310003441 | 310001442 | 1.87 | 62.1 | Palliative (P) | 2018-06-30 | 2018-07-24 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017940 | CISPLATIN + GEMCITABINE |
| 310003442 | 310006613 | 1.69 | 65.85 | Palliative (P) | 2015-03-07 | 2015-03-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017941 | CISPLATIN + GEMCITABINE |
| 310003443 | 310006613 | 1.63 | 14 | null | 2015-11-01 | 2015-11-01 | CISPLATIN + GEMCITABINE | N | null | 310017941 | CISPLATIN + GEMCITABINE |
| 310003444 | 310001443 | 1.78 | 99.4 | Palliative (P) | 2016-09-07 | 2016-09-16 | CISPLATIN + GEMCITABINE | null | N | 310017945 | CISPLATIN + GEMCITABINE |
| 310003445 | 310001443 | null | 61.6 | Palliative (P) | 2017-06-09 | 2017-06-10 | CHOP R - 21 days | N | N | 310017945 | CHOP R |
| 310003446 | 310001444 | 1.74 | 3.9 | Curative (C) | 2013-05-28 | 2013-06-01 | Cisplatin 7 day | 2 | N | 310017947 | CISPLATIN |
| 310003447 | 310001444 | 1.57 | 78 | Neo-adjuvant (N) | 2016-08-25 | 2016-09-01 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017947 | CISPLATIN + GEMCITABINE |
| 310003448 | 310001445 | null | 93 | Palliative (P) | 2014-03-03 | 2014-03-31 | PEMBROLIZUMAB | N | N | 310017957 | PEMBROLIZUMAB |
| 310003449 | 310006616 | 1.6 | 64.5 | Curative (C) | null | 2013-12-16 | Cisplatin 7 day | N | Y | 310017959 | CISPLATIN |
| 310003450 | 310001446 | null | 70 | Palliative (P) | 2017-04-07 | 2017-04-07 | Ipilimumab | 02 | null | 310017962 | IPILIMUMAB |
| 310003451 | 310006617 | 1.63 | 66.5 | Palliative (P) | 2013-01-24 | 2013-02-09 | DOXORUBICIN | N | N | 310017963 | DOXORUBICIN |
| 310003452 | 310009054 | 1.68 | 97.8 | Palliative (P) | 2017-12-12 | 2017-12-14 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017970 | CISPLATIN + GEMCITABINE |
| 310003453 | 310001447 | null | 12.5 | Curative (C) | 2016-12-21 | 2016-12-22 | Retinoblastoma JOE | N | N | 310017972 | CEV |
| 310003454 | 310006618 | 1.7 | null | Curative (C) | 2017-03-12 | 2017-03-12 | Cisplatin 7 day | 02 | N | 310017975 | CISPLATIN |
| 310003455 | 310006618 | null | null | Palliative (P) | 2014-07-30 | 2014-08-12 | Ipilimumab | 2 | N | 310017975 | IPILIMUMAB |
| 310003456 | 310006618 | null | 70 | Palliative (P) | null | 2017-03-22 | CISPLATIN + GEMCITABINE | 02 | null | 310017975 | CISPLATIN + GEMCITABINE |
| 310003457 | 310001448 | 1.65 | 70 | Palliative (P) | 2017-02-08 | 2017-02-08 | Doxorubicin 75mg/m2 | N | N | 310017978 | DOXORUBICIN |
| 310003458 | 310006619 | 1.6 | 5.1 | Neo-adjuvant (N) | 2015-02-06 | 2015-02-18 | CISPLATIN + GEMCITABINE | N | N | 310017980 | CISPLATIN + GEMCITABINE |
| 310003459 | 310006619 | 1.57 | 87 | Palliative (P) | 2018-06-16 | 2018-06-17 | Ipilimumab | 02 | N | 310017980 | IPILIMUMAB |
| 310003460 | 310010334 | 1.78 | 70.3 | Palliative (P) | 2014-04-13 | 2014-04-23 | Carboplatin + Etoposide iv&po | N | N | 310017985 | CARBOPLATIN + ETOPOSIDE |
| 310003461 | 310011042 | 1.66 | 58.15 | Palliative (P) | 2015-07-22 | 2015-08-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017987 | CISPLATIN + GEMCITABINE |
| 310003462 | 310011439 | 1.68 | 75.3 | null | 2018-02-13 | 2018-02-13 | DOXORUBICIN | 02 | N | 310017991 | DOXORUBICIN |
| 310003463 | 310001449 | 1.59 | 86 | Palliative (P) | 2016-03-13 | 2016-03-13 | PEMBROLIZUMAB | 02 | N | 310017995 | PEMBROLIZUMAB |
| 310003464 | 310001449 | 1.65 | 70 | Palliative (P) | 2018-11-21 | 2018-11-22 | PEMBROLIZUMAB | 02 | N | 310017995 | PEMBROLIZUMAB |
| 310003465 | 310001450 | 1.64 | 58 | Palliative (P) | 2014-10-29 | 2014-10-29 | Ipilimumab | N | N | 310017997 | IPILIMUMAB |
| 310003466 | 310001451 | 1.64 | 104 | Palliative (P) | null | 2015-11-03 | Cisplatin+Gemcitabine (Days 1&8&15) | N | N | 310017998 | CISPLATIN + GEMCITABINE |
| 310003467 | 310001452 | 1.62 | 97 | null | 2015-12-06 | 2015-12-19 | DOXORUBICIN | 2 | N | 310018000 | DOXORUBICIN |
| 310003468 | 310001453 | null | 70 | Curative (C) | null | 2015-03-11 | Retinoblastoma JOE | N | Y | 310018001 | CEV |
| 310003469 | 310001454 | 1.73 | 90.85 | Palliative (P) | 2014-05-06 | 2014-05-25 | DOXORUBICIN | N | N | 310018005 | DOXORUBICIN |
| 310003470 | 310001455 | 1.49 | 90 | Palliative (P) | 2017-12-06 | 2017-12-12 | PEMBROLIZUMAB | 02 | N | 310018006 | PEMBROLIZUMAB |
| 310003471 | 310001455 | null | 77 | Palliative (P) | 2015-10-13 | 2015-10-14 | Ipilimumab | 02 | N | 310018006 | IPILIMUMAB |
| 310003472 | 310001455 | 1.61 | null | null | 2017-08-05 | 2017-09-06 | Cisplatin | N | Y | 310018006 | CISPLATIN |
| 310003473 | 310001455 | 1.87 | 80.9 | Curative (C) | 2014-11-27 | 2014-11-28 | CHOP R - 21 days | 99 | N | 310018006 | CHOP R |
| 310003474 | 310001456 | 1.53 | 75 | Adjuvant (A) | 2015-02-14 | 2015-03-21 | CISPLATIN + GEMCITABINE | N | N | 310018013 | CISPLATIN + GEMCITABINE |
| 310003475 | 310001456 | 1.66 | 76.5 | Palliative (P) | null | 2014-02-27 | Ipilimumab | N | null | 310018013 | IPILIMUMAB |
| 310003476 | 310001456 | 1.79 | 69.4 | Curative (C) | 2014-10-26 | 2014-11-08 | CISPLATIN + GEMCITABINE | N | null | 310018013 | CISPLATIN + GEMCITABINE |
| 310003477 | 310001456 | 0 | 67 | Curative (C) | 2016-09-21 | 2016-10-14 | Retinoblastoma JOE | N | N | 310018013 | CEV |
| 310003478 | 310001457 | null | 80.6 | Disease modification (D) | 2017-04-02 | 2017-04-06 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 310018020 | CISPLATIN + GEMCITABINE |
| 310003479 | 310001458 | 1.73 | 14.6 | Palliative (P) | 2017-06-26 | 2017-06-26 | Ipilimumab | 02 | N | 310018023 | IPILIMUMAB |
| 310003480 | 310001459 | 1.64 | 17 | Curative (C) | 2017-09-12 | 2017-09-27 | Carboplatin + Etoposide iv&po | N | N | 310018026 | CARBOPLATIN + ETOPOSIDE |
| 310003481 | 310001459 | 1.79 | 80 | Palliative (P) | 2014-06-24 | 2014-06-25 | PEMBROLIZUMAB | N | N | 310018026 | PEMBROLIZUMAB |